Silvercrest Asset Management Group »

Madrigal Pharmaceuticals shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.4M 16k 523.47

More positions owned by Silvercrest Asset Management Group

Broadcom (AVGO)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
Apple (AAPL)
Cisco Systems (CSCO)
Element Solutions (ESI)
Alphabet Inc Class A cs (GOOGL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Williams Companies (WMB)
Johnson & Johnson (JNJ)
Atmos Energy Corporation (ATO)
BorgWarner (BWA)
Eaton (ETN)
SYNNEX Corporation (SNX)
Ametek (AME)

View all positions for Silvercrest Asset Management Group

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Henderson Group
Rtw Investments
venBio Select Advisor
BlackRock
Paulson & Co
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Citadel Advisors
FMR
Geode Capital Management
William Blair Investment Management
Invesco

View all funds holding Madrigal Pharmaceuticals